Remunity Pump News Today

Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average 12 month […]

United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1-year price […]

Jacobs Levy Equity Management Inc. lowered its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 14.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 192,676 shares of the biotechnology company’s stock after selling 31,881 shares during the quarter. Jacobs […]

Jacobs Levy Equity Management Inc. lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 14.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 192,676 shares of the biotechnology company’s stock after selling 31,881 shares during the quarter. Jacobs Levy Equity Management Inc.’s holdings in United Therapeutics were worth […]

United Therapeutics Co. (NASDAQ:UTHR – Free Report) – Analysts at Leerink Partnrs boosted their FY2027 EPS estimates for shares of United Therapeutics in a research note issued on Thursday, February 22nd. Leerink Partnrs analyst R. Ruiz now expects that the biotechnology company will post earnings per share of $24.40 for the year, up from their […]

United Therapeutics (NASDAQ:UTHR – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported $4.36 earnings per share for the quarter, topping analysts’ consensus estimates of $4.28 by $0.08, MarketWatch Earnings reports. The firm had revenue of $614.70 million during the quarter, compared to analysts’ expectations of $575.01 million. United Therapeutics […]

Covestor Ltd lowered its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings […]

Covestor Ltd reduced its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings in […]

Covestor Ltd lowered its position in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 30.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 812 shares of the biotechnology company’s stock after selling 362 shares during the period. Covestor Ltd’s holdings […]

HC Wainwright reissued their buy rating on shares of United Therapeutics (NASDAQ:UTHR – Free Report) in a research note issued to investors on Thursday, Benzinga reports. They currently have a $300.00 price target on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on the company. StockNews.com cut United Therapeutics […]